Home » Newsletters » BioWorld Science

BioWorld Science

March 7, 1997

View Archived Issues

Licensees/CRADA partners sought for antiprogestins

NIH offers MAbs for diagnosis and basic research for licensing

NIH seeks licensees for mutated 5-HT receptor

Invention related to antiretroviral compounds disrupting zinc fingers available for licensing

BioTransplant reports financial results for the year and fourth quarter 1996

Incyte reports fourth-quarter and year-end results

Transkaryotic Therapies reports year-end financial results

Neoprobe reports 1996 fourth-quarter and year-end results

PLC Systems reports fourth-quarter and year-end financial results

Bio-Technology General announces year-end 1996 earnings results

Dusa Pharmaceuticals reports 1996 highlights and financial results

OraVax reports fourth-quarter and year-end results

Roberts Pharmaceutical Corp. releases letter from the chairman

Mapping of hepatitis B core protein reported

New grant program for HIV vaccine research

Gene linked to juvenile macular degeneration cloned

Synaptic receives patent for "feeding" gene

Product for hair loss approved in Thailand

Incyte's LifeSeq database licensed to another top pharmaceutical company

Teva receives tentative approval for ketorolac tromethamine

Researcher receives NIH grant related to BRCA2 gene

Agrylin granted priority review in Canada

European approval sought for ultrasound imaging agent

AIT-082 enters clinic

Positive preliminary results for rotavirus vaccine

U.S. patent covers Immunex's TNFR

Vyrex and Immune Response form collaboration

OXIS completes preclinicals of restenosis treatment

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...